Weight loss drugs like Ozempic, Wegovy are all the rage. Are they safe for kids?

Weight loss drugs like Ozempic, Wegovy are all the rage. Are they safe for 
kids?

The Dallas Morning News. DALLAS — Weight loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to...
18 hours ago
from: The Daily Item

Continue reading...
Anti-obesity medication, GLP-1 receptor agonist, Health care, Obesity, Semaglutide, Weight loss
More about this
- Weight loss drugs are getting people to the doctor. Now comes the wave of long-ignored diagnoses
Demand for weight loss drugs like Ozempic is also boosting diagnoses of conditions such as sleep apnea and cardiovascular disease.
from: Quartz
- Future of Obesity Care: 3 Wishes from Thought Leader Donna Ryan, MD
When asked about her 3 wishes for the future of obesity care, Donna Ryan, MD, told Patient Care that she had just one: access.
from: Patient Care Online
- Growth, Volume, Price: The Skinny on GLP-1 Medications
For the 40% of American adults with obesity, glucagon-like peptide-1 receptor agonists, or GLP-1 drugs, may offer hope—but the cost can put...
from: National Conference of State Legislatures
- Do the new weight-loss drugs improve your health?
The FDA has approved three GLP-1 receptor agonist drugs for weight loss. The drugs not only lower blood sugar and weight, but also reduce...
from: Harvard Health
- Mindy Grupe - Non-Surgical Weight Loss, Patient Story
Mindy Grupe wanted to lose at least 100 pounds to overcome her health problems. Yet, bariatric surgery seemed a more extreme step than she...
from: MercyOne
- Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with obesity-related...
from: Hawaii Tribune-Herald
- Can weight loss drugs reduce healthcare costs?
In today's Finshots, we explore how weight loss drugs are being touted as a way to cut healthcare costs in the US and whether they really...
from: Finshots
- Weight loss drugs are getting people to the doctor. Now comes the wave of long-ignored diagnoses
Popular weight-loss drugs like Wegovy and Zepbound are boosting the use of healthcare in the U.S., leading to an uptick in patients getting...
from: Yahoo
- Expert Perspectives 2024: The Dynamic Future of Obesity Medicine, with Donna Ryan, MD
The future of obesity medicine is filled with promise as GLP-1 RAs and other peptides continue to demonstrate pluripotency in metabolic...
from: Patient Care Online